These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 16159227)

  • 1. Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology.
    Khaled A; Guo S; Li F; Guo P
    Nano Lett; 2005 Sep; 5(9):1797-808. PubMed ID: 16159227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA nanotechnology: engineering, assembly and applications in detection, gene delivery and therapy.
    Guo P
    J Nanosci Nanotechnol; 2005 Dec; 5(12):1964-82. PubMed ID: 16430131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of folate-conjugated pRNA of bacteriophage phi29 DNA packaging motor for delivery of chimeric siRNA to nasopharyngeal carcinoma cells.
    Guo S; Huang F; Guo P
    Gene Ther; 2006 May; 13(10):814-20. PubMed ID: 16482206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific delivery of therapeutic RNAs to cancer cells via the dimerization mechanism of phi29 motor pRNA.
    Guo S; Tschammer N; Mohammed S; Guo P
    Hum Gene Ther; 2005 Sep; 16(9):1097-109. PubMed ID: 16149908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of 14 different RNA nanoparticles for specific tumor targeting without accumulation in normal organs.
    Shu Y; Haque F; Shu D; Li W; Zhu Z; Kotb M; Lyubchenko Y; Guo P
    RNA; 2013 Jun; 19(6):767-77. PubMed ID: 23604636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Delivery of Anti-miRNA for Suppression of Triple Negative Breast Cancer Utilizing RNA Nanotechnology.
    Shu D; Li H; Shu Y; Xiong G; Carson WE; Haque F; Xu R; Guo P
    ACS Nano; 2015 Oct; 9(10):9731-40. PubMed ID: 26387848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Favorable biodistribution, specific targeting and conditional endosomal escape of RNA nanoparticles in cancer therapy.
    Xu C; Haque F; Jasinski DL; Binzel DW; Shu D; Guo P
    Cancer Lett; 2018 Feb; 414():57-70. PubMed ID: 28987384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
    Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
    ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineering RNA-protein complexes with different shapes for imaging and therapeutic applications.
    Osada E; Suzuki Y; Hidaka K; Ohno H; Sugiyama H; Endo M; Saito H
    ACS Nano; 2014 Aug; 8(8):8130-40. PubMed ID: 25058166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlling RNA self-assembly to form filaments.
    Nasalean L; Baudrey S; Leontis NB; Jaeger L
    Nucleic Acids Res; 2006; 34(5):1381-92. PubMed ID: 16522648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methods for assembling B-cell lymphoma specific and internalizing aptamer-siRNA nanoparticles via the sticky bridge.
    Zhou J; Rossi JJ; Shum KT
    Methods Mol Biol; 2015; 1297():169-85. PubMed ID: 25896003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assembly of therapeutic pRNA-siRNA nanoparticles using bipartite approach.
    Shu Y; Cinier M; Fox SR; Ben-Johnathan N; Guo P
    Mol Ther; 2011 Jul; 19(7):1304-11. PubMed ID: 21468002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor.
    Lee TJ; Haque F; Vieweger M; Yoo JY; Kaur B; Guo P; Croce CM
    Methods Mol Biol; 2015; 1297():137-52. PubMed ID: 25896001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA self-assembly and RNA nanotechnology.
    Grabow WW; Jaeger L
    Acc Chem Res; 2014 Jun; 47(6):1871-80. PubMed ID: 24856178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multifunctional polyamidoamine-modified selenium nanoparticles dual-delivering siRNA and cisplatin to A549/DDP cells for reversal multidrug resistance.
    Zheng W; Cao C; Liu Y; Yu Q; Zheng C; Sun D; Ren X; Liu J
    Acta Biomater; 2015 Jan; 11():368-80. PubMed ID: 25204523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific delivery of delta-5-desaturase siRNA via RNA nanoparticles supplemented with dihomo-γ-linolenic acid for colon cancer suppression.
    Xu Y; Pang L; Wang H; Xu C; Shah H; Guo P; Shu D; Qian SY
    Redox Biol; 2019 Feb; 21():101085. PubMed ID: 30584980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design Strategy to Access siRNA-Encapsulating DNA "Nanosuitcases" That Can Conditionally Release Their Cargo.
    Bujold KE; Fakih HH; Sleiman HF
    Methods Mol Biol; 2019; 1974():69-81. PubMed ID: 31098996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-step assembly of cationic lipid-polymer hybrid nanoparticles for systemic delivery of siRNA.
    Yang XZ; Dou S; Wang YC; Long HY; Xiong MH; Mao CQ; Yao YD; Wang J
    ACS Nano; 2012 Jun; 6(6):4955-65. PubMed ID: 22646867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Versatile RNA tetra-U helix linking motif as a toolkit for nucleic acid nanotechnology.
    Bui MN; Brittany Johnson M; Viard M; Satterwhite E; Martins AN; Li Z; Marriott I; Afonin KA; Khisamutdinov EF
    Nanomedicine; 2017 Apr; 13(3):1137-1146. PubMed ID: 28064006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Delivery of MiRNA for High Efficient Inhibition of Prostate Cancer by RNA Nanotechnology.
    Binzel DW; Shu Y; Li H; Sun M; Zhang Q; Shu D; Guo B; Guo P
    Mol Ther; 2016 Aug; 24(7):1267-77. PubMed ID: 27125502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.